Among them, DLEU2 showed the highest upregulation (22.48 fold change) and CECR9 the most downregulated (4.55 fold change) in J82 BC cells compared to SV-HUC-1 normal bladder epithelial cells, as confirmed by RT-qPCR (Fig. 1C). This evidence concerns the gene CECR9 and breast cancer.